Header Logo

Connection

Kathleen Moore to Enzyme Inhibitors

This is a "connection" page, showing publications Kathleen Moore has written about Enzyme Inhibitors.
Connection Strength

0.525
  1. PARP inhibition in ovarian cancer: state of the science. Gynecol Oncol. 2015 Jan; 136(1):8-10.
    View in: PubMed
    Score: 0.430
  2. A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors. Invest New Drugs. 2014 Feb; 32(1):87-93.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.